The prevalence of transfusion-transmissible infections (TTIs) in blood donations is important for evaluating blood safety and potential risks to the population. This study investigated the prevalence of TTIs among blood donors in Western China and suggested measures for policy-makers.
The screening results of 66,311 donations between 2005 and 2010 from a central blood center in Western China were analyzed. The prevalence of hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), and syphilis infections were expressed in percentages for the entire study group as well as groups by demographic characteristics and donation frequency, with differences analyzed using Fisher's exact or Chi-square test. Logistic regression was performed to identify the influencing factors of the detected results.
1,769 (2.67%, 95% CI 2.55–2.79%) of the donated blood had serological evidence of infection with at least one pathogen and 44 (0.07%, 95% CI 0.05–0.09%) showed evidence of multiple infections. The seroprevalence of HBV, HCV, HIV, and syphilis infections was 0.87% (95% CI 0.80–0.94%), 0.86% (95% CI 0.79–0.93%), 0.31% (95% CI 0.26–0.35%), and 0.70% (95% CI 0.64–0.76%) respectively. Trend analysis for the prevalence of TTIs showed a significant increase from 2.44% to 3.71% (χ2 = 100.72, p = 0.00) over this 6-year period. The positive rates for TTIs varied along demographic lines. The top three risk factors in test-positive donors were identified as age, education level and donation frequency. The older age group and lower educated group were linked to a higher prevalence of TTIs. A decreasing prevalence was associated with an increasing frequency of blood donations (χ2 = 562.78, p = 0.00).
Citation: Song Y, Bian Y, Petzold M, Ung COL (2014) Prevalence and Trend of Major Transfusion-Transmissible Infections among Blood Donors in Western China, 2005 through 2010. PLoS ONE9(4): e94528. https://doi.org/10.1371/journal.pone.0094528
Editor: Michael Alan Polis, National Institute of Allergy and Infectious Diseases, United States of America
Received: July 16, 2013; Accepted: March 17, 2014; Published: April 8, 2014
Copyright: © 2014 Song et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The authors have no support or funding to report.
Competing interests: The authors have the following interests: Chengdu blood center in Sichuan province, China provided technical assistance. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Blood transfusion and component therapies are well-established and essential medical practices. These therapies, however, are not without risks and may lead to the transmissions of infectious agents from donor to recipient. Common infectious agents include hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV) and syphilis–causing T. pallidum . The HIV crisis related to blood donation in China has been well documented –. Collection of unhygienic plasma/blood in some rural areas of China during the mid-1990s led to regional HIV epidemics . The Joint United Nations Program on HIV/AIDS (UNAIDS) reported that of 75,000 HIV infections in China in 2005, 22,000 were acquired through transfusions of contaminated blood . In addition, many cases of HBV and HCV infections in Chinese adults were found to be associated with blood transfusions , . HBV prevalence of 10% and HCV prevalence of 3.2% were observed in the general population meaning hepatitis was an endemic in China . The prevalence of HCV infection among blood donors on the Chinese mainland from 1990 to 2010 was 8.68% .
In pursuit of global blood safety, the World Health Organization (WHO) recommends that all blood donations should be screened for evidence of infection prior to the release of blood and blood components for clinical or manufacturing use . According to WHO guidelines, the screening of all blood donations should be mandatory for HIV, HBV, HCV and syphilis. Transfusion-transmissible infections (TTIs) have been drastically reduced in countries where routine serologic screening of donors is implemented , . Nevertheless, there are still risks of TTIs due to the limitations of virus detection techniques. The median prevalence rate of TTIs in blood donations in middle- and low-income countries is much higher than that in high-income countries . TTIs remain a significant threat to blood safety, causing grave concerns in many developing countries.
The prevalence of viral infections in blood donations can be used as a valuable indicator to assess the safety of blood supply and the potential risk of TTIs. Changes in this prevalence may also reflect trends in the infections of interests among the general population. At present, there is no comprehensive data about overall seroprevalence of major TTIs among blood donor groups in China, especially in underdeveloped western areas of China. In this study, we analyzed the data of screening tests on blood donations at a central blood center in Western China, examined the presence of hepatitis B virus surface antigen (HBsAg), anti-HCV, anti-HIV, and anti-TP (marker for syphilis infection) among blood donors, and explored the influencing factors of the detected results. Based on the findings, measures to improve blood safety through TTI prevention and control were suggested for policy-makers' consideration to minimize the risks of TTIs and safeguard public health in China.
The study protocol was approved by the Ethics Committee of the Institution of Chinese Medical Sciences, University of Macau. It did not require review in Western China since all the samples were anonymized. All donors at the central blood center in China were volunteers and, prior to blood donations, had to be verified for eligibility according to the current Chinese national blood donation criteria. Only those aged between 18 and 55 years, having a body weight above 50 kg for males and 45 kg for females, as well as physically and mentally fit would be accepted as eligible donors. In this study, written informed consent was obtained from all participants to allow the use of anonymized test results of their blood samples.
This cross-sectional study was performed in the largest multifunctional blood transfusion service center in Western China. Western China includes 10 provinces, municipalities and autonomous regions: Shaanxi, Gansu, Qinghai, Ningxia, Xinjiang, Sichuan, Chongqing, Yunnan, Guizhou, and Xizang. The region covers 5.38 million square kilometers, 56% of the land area of the country, and has a population of 287 million people, 22.99% of the national total . In short, Western China is insufficiently industrialized and is relatively undeveloped compared with the eastern region of China. The sample site of the study is located in Sichuan Province, a large agricultural province and a key economic center of Western China, having a population of 80.42 million in 2010 . The volume of donated blood averaged 40 tons each year at the sample site. Considering April was usually the donation peak month, data of all donated blood each April from 2005 to 2010 were requested and obtained for this study, amounting to 66,311 cases in total. The test results of these donations underwent anonymizations with the resultant information showing only donor demographic characteristics, donation frequencies and TTI screening results among the donors.
At this central blood center, all potential donors first went through the pre-donation rapid testing procedures which tested for HBsAg. Then, all donor samples underwent two rounds of enzyme immunoassays (EIA) using two different reagents to test for anti-HIV-1, anti-HIV-2, anti-HCV and HBsAg. Syphilis antibody was also tested with Rapid Plasma Reagin (RPR) and enzyme-linked immunosorbent assay (ELISA) respectively. All reagents used in screening tests are listed in Table 1. All kits were approved and licensed by the Chinese State Food and Drug Administration. Blood samples were considered positive for TTI if any screening test showed positive results.
Data were coded, entered, cleaned, validated and analyzed using IBM SPSS Statistics 19.0 (Armonk, New York, USA). The prevalence of TTIs was determined by the number of donations with positive TTI serologic markers in a year divided by the total number of blood donations in that year. The positivity rates of HBsAg, anti-HCV, anti-HIV, and anti-TP were expressed in percentages for the entire study group and groups with different demographic characteristics and donation frequencies. The comparisons between/among groups were performed using Fisher's exact test. Chi-square trend test was applied to examine the variation in trends. Logistic regression was employed to explore the influencing factors of the detected results: the dependent variable was the screening result (0 for negative and 1 for positive); the independent variables included gender, age, ethnic group, occupation, education level, donation frequency and the amount of donated blood.
The characteristics of the study population are shown in Table 2. 51.07% were female and 48.93% were male. Their ages (in years) ranged from 18 to 55, with 18–29 years as the largest age group contributing to 43,401 donations (65.45% of donors). Among the donors, 97.8% were Han Chinese, 68.39% were single and 56.32% had a college degree or higher level of education. Nearly two-thirds were first-time donors and the percentage of first-time donation increased annually (χ2 = 637.57, p = 0.00).
Among the 66,311 blood donors, 1,769 were confirmed positive for at least one pathogen, giving a prevalence of TTIs at 2.67% (95% CI 2.55–2.79%). The overall positivity rates of HBsAg, anti-HCV, anti-HIV, and anti-TP were 0.87% (95% CI 0.80–0.94%), 0.86% (95% CI 0.79–0.93%), 0.31% (95% CI 0.26–0.35%), and 0.70% (95% CI 0.64–0.76%) respectively. 1,725 (2.60%, 95% CI 2.48–2.72%) of the donated blood had serological evidence of infection with only one pathogen and 44 (0.07%, 95% CI 0.05–0.09%) had multiple infections (Maximum = 3). The top three concurrent infections were HIV and syphilis (15), HBV and syphilis (14) and HCV and syphilis (8). Over this 6-year period, trend analysis for risks of TTIs showed a significant increase from 2.44% to 3.71% (χ2 = 100.72, p = 0.00). The results of confirmed viral markers tested in each year are presented in Table 3. Significant increases were noted in the prevalence of HCV, HIV and syphilis infections after 2007. The prevalence of HBV varied in a range between 0.70% and 1.07% from 2005 to 2010 with no statistical significance (p = 0.11). Overall, HBsAg was the most prevalent pathogen in the six years.
Positivity rate by demographic characteristics
Table 4 shows the TTI positivity rates for groups with different demographic characteristics. The prevalence of TTIs was 2.66% for male and 2.67% for female in the donation population, without significant gender difference (p>0.05). HBV and syphilis infections were more prevalent among the males whereas HCV and HIV infections were more prevalent among the females, but none of the differences were significant (p>0.05). The prevalence of HBV, HCV, HIV and syphilis infections increased with age. The rate of TTI positive donations was higher in the married group. The prevalence of HBV, HCV, HIV and syphilis infections among married donors was 1.05%, 0.94%, 0.35% and 1.12%, respectively. The TTIs prevalence also showed significant differences among different education levels (χ2 = 72.47, p = 0.00). The positivity rate was lower in higher educated groups. Regarding occupation, farmers showed the highest incidence (4.30%) of TTIs while health care workers (2.35%) and students (2.27%) ranked as the bottom two.
Positivity rate by donation frequency
Among all donors, the prevalence of TTIs was 3.79% (95% CI 3.60–3.97%) for first-time donors, 1.29% (95% CI 1.09–1.48%) for donors who donated twice, and 0.71% (95% CI 0.57–0.86%) for donors who had donated three times or more (Table 5). A significant decrease in the prevalence was linked to the increased frequency of blood donations (χ2 = 562.78, p = 0.00). The most common TTI in first-time donors was HBV infection, followed by HCV infection.
Influencing factors of TTI prevalence
In multivariable logistic regression analysis, the covariate variables were run as factor variables and the occurrence of TTI positive donations was independently associated with age, education level and donation frequency (Table 6). The regression result implied that: 1) more positive donations were found in the older age group; 2) lower educated donors were more likely to be confirmed positive for TTIs; 3) the TTI positivity rate was lower in repeat donors.
This study showed that 2.67% of the donated blood was seropositive for at least one of the screened markers. This number is comparatively low in China, as reports showed the seropositivity rate in donors ranged from 2.5% to 7% in other parts of China . However, the seropositivity rate of 2.67% is considered very high compared with other developing countries , , posing great concerns about blood safety and promoting the need for stringent donor selection criteria and blood screening measures. It was also noted that 44 (0.07%) of donated blood specimens had serological evidence of multiple infections with syphilis and HIV as the most common concurrent infections, followed by syphilis and HBV. These coinfections should always be screened as a matter of priority.
In this study, the prevalence rate of HIV infection in the blood center in Western China (0.31%) was much higher than that in the general population (0.05%) . This observation is not consistent across different areas of China. Given varying HIV prevalence rates among different regions in China, with Liaoning (0.22%) and Yancheng (0.18%) displaying a HIV prevalence rate among blood donors four to ten times higher than that in Guangzhou (0.02%) and Nanjing (0.08%) , further investigation is needed to explain this finding.
HBV has been a well-recognized public health concern in China for a long time. In compliance with international recommendations of vaccination to prevent and control HBV, a nationwide HBV vaccination program was implemented in 1992, and free HBV vaccination was provided for all neonates after 2005. Since then the prevalence of HBV infection in the general population has dropped significantly , . With an effective vaccination coverage, the HBsAg carrier rate in the general population decreased from 9.8% to 7.2% in 2006. In particular, the prevalence of HBV infection decreased from 9–12% to 2.3% among children aged 5–14 years and was as low as 1.0% among children younger than 5 years in 2006 , . Although the positive impact of the vaccination program on donated blood safety is too preliminary to establish at this stage, vaccination is considered as a highly effective measure to minimize HBV in donated blood in the long term. Meanwhile, the prevalence of HBV infection in China remains very high with approximately 100 million individuals having chronic HBV infection . The significantly lower seroprevalence of HBV infection among the donor population (0.87%) in this study suggested that the pre-donation HBsAg rapid testing was critical for controlling risks.
The prevalence rate for HCV infection in blood donors was revealed to be 0.86% which is lower than that in the general population . The Blood Donation Law implemented in 1998 in China, which only allowed voluntary blood donors, has played a major role in controlling the spread of HCV. In addition, the detection techniques for anti-HCV have been greatly improved, with better sensitivity and specificity in recent years. All these measures lead to a drastic decline in HCV prevalence throughout China after 1998. But infections of HBV and HCV remained common in this region.
Before 1998, TTIs were very common in China due to contaminated blood collections, particularly in for-profit plasma collection facilities. As the Blood Donation Law came into effect in 1998, blood collection was successfully shifted from paid and employer-organized donations to fully voluntary donations. The government also implemented a standardized national donor screening policy. The safety of blood supply and transfusion in China has been greatly enhanced. However, all the rates of TTI positive donations observed in our study showed an increased trend in the last two years, which is different from the decreasing trends reported in Western countries or other Asian countries –. This increase might be due to two reasons. Firstly, the sensitivity of reagents or methods used in blood screening tests has improved, leading to the increase in the number of positive confirmations. Secondly, the increasing trend of TTIs in the donated blood may be associated with the increased number of first-time donors in the last two years of the study. It has been well-documented that first-time blood donors always pose a greater risk of infectious donation than repeat donors –. Furthermore, the boost in the number of positive cases might be caused by people with suspected infections who opted for free blood screening tests at the center.
In accordance with other research results in China, our findings indicated that the TTI positive donations were independently associated with age, education level, and donation frequency , . In terms of age, most of the younger donors were studying at university and were under supervision not only educationally but also socially. Almost all university students in China are required to live in boarding facilities bound by the strict regulations of the universities which might have compromised their social freedom. The younger generation would only have a relatively more active sex life, and thus higher disease susceptibility, upon graduation. As a result, the chance of infections was found to be low in the younger age group. More positive results of TTIs were also found in the low education level group. This could be explained by the fact that the higher educated groups have better understandings of screening educational materials and may defer from donations when at risk. This finding also conformed to the implication of Knowledge-Attitude- Practice (KAP) theory. In order to ensure long-term progress in blood supply safety, young people and higher educated groups should be encouraged to donate blood.
Furthermore, in line with other research, higher rates of TTIs were observed among first-time donors in our study and the prevalence decreased as the number of previous donations increased. Repeat donors might be better informed candidates who would deny risk behaviors before donations, and were tested negative at their prior donation so as to reduce the probability of blood infections in the window period. Moreover, it is believed that most repeat donors would not suddenly engage in high-risk behaviors. In order to help ensure the safety of blood supply, not only should new donors be carefully recruited to maintain the volume of the donation pool, but a cadre of previous donors should also be actively retained.
In conclusion, the seroprevalence of certain TTIs appeared to be lower among blood donors than that in the general population of China. This is largely due to the effective system to select donors and screen donated blood. However, hepatitis B and C were found most, and often in conjunction with syphilis. These were the primary threats to blood safety. The increasing trend of blood-borne infections in blood donors since 2007 calls for more stringent measures. More sensitive screening methods such as nucleic acid testing should be adopted to help detect TTIs earlier and thus reduce the risks associated with window periods. It is also considered highly important to improve donor recruitment procedures and increase the proportion of regular donors. Young people, higher educated groups and previous donors should be encouraged to donate blood to help ensure a long-term safe blood supply.
The authors wish to thank the Chengdu blood center in Sichuan province, China for their technical assistance.
Conceived and designed the experiments: YB. Performed the experiments: YS YB. Analyzed the data: YS MP COLU. Contributed reagents/materials/analysis tools: YB. Wrote the paper: YS COLU.
- 1. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ (1996) The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 334: 1685–1690.
- 2. Shan H, Wang JX, Ren FR, Zhang YZ, Zhao HY, et al. (2002) Blood banking in China. Lancet 360: 1770–1775.
- 3. Erwin K (2006) The circulatory system: blood procurement, AIDS, and the social body in China. Med Anthropol Q 20: 139–159.
- 4. Adams V, Erwin K, Le PV (2009) Public health works: blood donation in urban China. Soc Sci Med 68: 410–418.
- 5. Dong R, Qiao X, Jia W, Wong M, Qian H, et al. (2011) HIV, HCV, and HBV co-infections in a rural area of Shanxi province with a history of commercial blood donation. Biomed Environ Sci 24: 207–213.
- 6. China MoH, WHO UNAIDS (2006) 2005 Update on the HIV/AIDS Epidemic and Response in China. Beijing.
- 7. Shepard CW, Finelli L, Alter MJ (2005) Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5: 558–567.
- 8. Guo XC, Wu YQ (1999) A review: progress of prevention and control on viral hepatitis in China. Biomed Environ Sci 12: 227–232.
- 9. Gao X, Cui Q, Shi X, Su J, Peng Z, et al. (2011) Prevalence and trend of hepatitis C virus infection among blood donors in Chinese mainland: a systematic review and meta-analysis. BMC Infect Dis 11: 88.
- 10. WHO (2009) Screening donated blood for transfusion-transmissible infections: recommendations. Geneva: WHO.
- 11. Christensen P, Groenbaek K, Krarup H (1999) Transfusion-acquired hepatitis C: the Danish look back experience. Transfusion 39.
- 12. Chiavetta JA, Escobar M, Newman A, He Y, Driezen P, et al. (2003) Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990–2000. CMAJ 169: 767–773.
- 13. WHO (2009) 100% Voluntary Non–Remunerated Donation of Blood and Blood Components. Melbourne, Australia.
- 14. ChinaWindow (2013). Western Region Development. Available: http://www.china-window.com/china_market/china_industry_reports/western-region-developmen.shtml. Accessed 12 January 2014.
- 15. National Bureau of Statistics of China (2012) Report of the national population census. Available: http://www.stats.gov.cn/tjsj/tjgb/rkpcgb/dfrkpcgb/201202/t20120228_30404.html. Accessed 10 January 2014.
- 16. Shang G, Seed CR, Wang F, Nie D, Farrugia A (2007) Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004. Transfusion 47: 529–539.
- 17. Mathai J, Sulochana PV, Satyabhama S, Nair PK, Sivakumar S (2002) Profile of transfusion transmissible infections and associated risk factors among blood donors of Kerala. Indian J Pathol Microbiol 45: 319–322.
- 18. Kafi-abad SA, Rezvan H, Abolghasemi H, Talebian A (2009) Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007. Transfusion 49: 2214–2220.
- 19. Li C, Xiao X, Yin H, He M, Li J, et al. (2012) Prevalence and prevalence trends of transfusion transmissible infections among blood donors at four Chinese regional blood centers between 2000 and 2010. J Transl Med 10: 176.
- 20. Liang X, Bi S, Yang W, Wang L, Cui G, et al. (2009) Epidemiological serosurvey of hepatitis B in China—declining HBV prevalence due to hepatitis B vaccination. Vaccine 27: 6550–6557.
- 21. Luo Z, Li L, Ruan B (2012) Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period. Int J Infect Dis 16: e82–88.
- 22. Xia GL, Liu CB, Cao HL (1996) Prevalence of hepatitis B and C virus infections in the general Chinese population: results from a nationwide cross-sectional seroepidemiologic study of hepatitis A, B, C, D and E virus infections in China, 1992. Int Hepatol Commun 5: 62–73.
- 23. Liang X, Bi S, Yang W, Wang L, Cui G, et al. (2009) Evaluation of the impact of hepatitis B vaccination among children born during 1992–2005 in China. J Infect Dis 200: 39–47.
- 24. Soldan K, Barbara JA, Ramsay ME, Hall AJ (2003) Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993–2001. Vox Sang 84: 274–286.
- 25. Kim MJ, Park Q, Min HK, Kim HO (2012) Residual risk of transfusion-transmitted infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 2010. BMC Infect Dis 12: 160.
- 26. Zou S, Notari EPt, Stramer SL, Wahab F, Musavi F, et al. (2004) Patterns of age- and sex-specific prevalence of major blood-borne infections in United States blood donors, 1995 to 2002: American Red Cross blood donor study. Transfusion 44: 1640–1647.
- 27. Ameen R, Sanad N, Al-Shemmari S, Siddique I, Chowdhury RI, et al. (2005) Prevalence of viral markers among first-time Arab blood donors in Kuwait. Transfusion 45: 1973–1980.
- 28. Soldan K, Davison K, Dow B (2005) Estimates of the frequency of HBV, HCV, and HIV infectious donations entering the blood supply in the United Kingdom, 1996 to 2003. Euro Surveill 10: 17–19.
- 29. Shang G, Seed C, Wang F, Nie D, Farrugia A (2007) Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004. Transfusion 47: 529–539.
- 30. Wang DW, Wang TB, Liu FP, Zhou YM (2008) Multivariable logistic regression analysis of syphilis infection in blood donations. Chinese Journal of Tropical Medicine 8: 822–824.
- 31. Wen GX, Gui X, Song XP, Zhao JL (2010) Analysis of blood safety factors in blood donation based on multivariable regression. Chinese Journal of Blood Transfusion 23: 937–940.